YU47116B - Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata - Google Patents

Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata

Info

Publication number
YU47116B
YU47116B YU211087A YU211087A YU47116B YU 47116 B YU47116 B YU 47116B YU 211087 A YU211087 A YU 211087A YU 211087 A YU211087 A YU 211087A YU 47116 B YU47116 B YU 47116B
Authority
YU
Yugoslavia
Prior art keywords
carbon atoms
alkyl
halogen
alkoxy
substituted
Prior art date
Application number
YU211087A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU211087A (en
Inventor
R.A. Bergman
H. Bundgaard
P.L. Lindberg
G.E. Sunden
Original Assignee
Aktiebolaget Hassle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8604998A external-priority patent/SE8604998D0/xx
Priority claimed from SE8605551A external-priority patent/SE8605551D0/xx
Priority claimed from SE8704049A external-priority patent/SE8704049D0/xx
Application filed by Aktiebolaget Hassle filed Critical Aktiebolaget Hassle
Publication of YU211087A publication Critical patent/YU211087A/xx
Publication of YU47116B publication Critical patent/YU47116B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
YU211087A 1986-11-21 1987-11-20 Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata YU47116B (sh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8604998A SE8604998D0 (sv) 1986-11-21 1986-11-21 Novel pharmacological compounds
SE8605551A SE8605551D0 (sv) 1986-12-23 1986-12-23 Novel pharmacological compounds
SE8704049A SE8704049D0 (sv) 1987-10-16 1987-10-16 Novel pharmacological compounds

Publications (2)

Publication Number Publication Date
YU211087A YU211087A (en) 1988-12-31
YU47116B true YU47116B (sh) 1994-12-28

Family

ID=27355365

Family Applications (1)

Application Number Title Priority Date Filing Date
YU211087A YU47116B (sh) 1986-11-21 1987-11-20 Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata

Country Status (24)

Country Link
EP (3) EP0279149B1 (enExample)
JP (1) JPH02500744A (enExample)
KR (1) KR890700125A (enExample)
AT (1) ATE84032T1 (enExample)
AU (1) AU612129B2 (enExample)
DE (1) DE3783356T2 (enExample)
DK (1) DK365488A (enExample)
EG (1) EG18379A (enExample)
ES (1) ES2052603T3 (enExample)
FI (1) FI892454L (enExample)
GR (1) GR3007385T3 (enExample)
HU (1) HU204814B (enExample)
IE (2) IE61178B1 (enExample)
IL (1) IL84504A (enExample)
IS (1) IS1565B (enExample)
LV (1) LV10954B (enExample)
MY (1) MY101784A (enExample)
NO (1) NO173998C (enExample)
NZ (2) NZ234564A (enExample)
PL (1) PL157655B1 (enExample)
PT (1) PT86186B (enExample)
RU (1) RU2062778C1 (enExample)
WO (1) WO1988003921A1 (enExample)
YU (1) YU47116B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801907D0 (sv) * 1988-05-20 1988-05-20 Haessle Ab Novel pharmacological compounds
WO1990003373A1 (fr) * 1988-09-20 1990-04-05 Hisamitsu Pharmaceutical Co., Inc. NOUVEAUX DERIVES DE DIBENZ[b,e]OXEPINE
IE64199B1 (en) * 1988-12-22 1995-07-12 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
PL165898B1 (pl) * 1990-06-20 1995-02-28 Astra Ab Sposób wytwarzania nowych pochodnych dwualkoksyplrydynylobenzlmldazolu PL
EP0481764B1 (en) * 1990-10-17 2000-03-29 Takeda Chemical Industries, Ltd. Pyridine derivatives, their production and use
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
WO1993023409A1 (fr) * 1992-05-21 1993-11-25 Otsuka Pharmaceutical Factory, Inc. Derive de diester phosphonique
AU6556894A (en) * 1993-05-18 1994-12-12 Upjohn Company, The Bisphosphonate esters for treating gastric disorders
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
EP0983263A1 (en) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
EP1051181B1 (en) * 1997-12-31 2004-03-17 The University Of Kansas Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof
ZA9810765B (en) * 1998-05-28 1999-08-06 Ranbaxy Lab Ltd Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
AU2583901A (en) * 1999-12-17 2001-06-25 Ariad Pharmaceuticals, Inc. Proton pump inhibitors
AU2001294228A1 (en) * 2000-10-12 2002-04-22 Takeda Chemical Industries Ltd. Benzimidazole compounds, process for producing the same and use thereof
WO2004009583A2 (en) * 2002-07-19 2004-01-29 Garst Michael E Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor
US20040248941A1 (en) * 2001-09-25 2004-12-09 Keiji Kamiyama Benzimidazone compound, process for producing the same, and use thereof
GB0400781D0 (en) * 2004-01-14 2004-02-18 Novartis Ag Organic compounds
KR20070046194A (ko) * 2004-08-27 2007-05-02 라보라토리오스 델 드라. 에스테브.에스.에이. 시그마 수용체 저해제
DK1913009T3 (da) * 2005-07-28 2010-08-16 Intervet Int Bv Nye benzimidazol(thio)carbamater med antiparasitisk virkning samt syntese heraf
US10272070B2 (en) 2014-10-14 2019-04-30 The Board of Trustees of the Leland Stanford Junio r University Method for treating neurodegenerative diseases
ES2830447T3 (es) 2015-12-15 2021-06-03 Univ Leland Stanford Junior Método para la prevención y/o el tratamiento del deterioro cognitivo asociado al envejecimiento y la neuroinflamación
CN112805000A (zh) * 2018-08-06 2021-05-14 小利兰·斯坦福大学董事会 作为ppargc1a激活剂用于治疗神经退行性疾病的2-芳基苯并咪唑
MX2022001820A (es) * 2019-08-20 2022-03-17 Ono Pharmaceutical Co Sal y forma cristalina de un compuesto que tiene actividad agonista para el receptor 5 de esfingosina-1-fosfato [acido (2s,3r,4e)-2-amino-3-hidroxioctadeca-4-enil-1-fosforico (s1p5).

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (enExample) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS5836312B2 (ja) * 1978-08-21 1983-08-08 日本電信電話株式会社 通信用平衡ケ−ブル線路の障害位置測定方式
JPS5687818A (en) * 1979-12-19 1981-07-16 Ishikawajima Harima Heavy Ind Co Ltd Reflex type position detector
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
JPS57137860A (en) * 1981-02-20 1982-08-25 Sumitomo Electric Ind Ltd Optical tachometer
JPS5999597A (ja) * 1982-11-30 1984-06-08 株式会社東芝 光学測定装置
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
JPS6020051U (ja) * 1983-07-19 1985-02-12 三洋電機株式会社 カセツト収納装置
AU568441B2 (en) 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds

Also Published As

Publication number Publication date
PL157655B1 (pl) 1992-06-30
DE3783356D1 (de) 1993-02-11
EP0279149B1 (en) 1992-12-30
IE940326L (en) 1988-05-21
DK365488D0 (da) 1988-07-01
DE3783356T2 (de) 1993-04-15
HU204814B (en) 1992-02-28
MY101784A (en) 1992-01-17
PL268927A1 (en) 1989-01-23
ATE84032T1 (de) 1993-01-15
NZ222495A (en) 1991-04-26
IS3284A7 (is) 1988-05-22
ES2052603T3 (es) 1994-07-16
AU612129B2 (en) 1991-07-04
NO173998C (no) 1994-03-02
AU8330287A (en) 1988-06-16
IL84504A (en) 1994-10-07
IS1565B (is) 1994-12-13
NO883229D0 (no) 1988-07-20
EP0279149A2 (en) 1988-08-24
RU2062778C1 (ru) 1996-06-27
LV10954A (lv) 1995-12-20
EP0279149A3 (en) 1988-08-31
FI892454A0 (fi) 1989-05-19
PT86186A (en) 1987-12-01
EP0332647A1 (en) 1989-09-20
HUT51269A (en) 1990-04-28
IE61178B1 (en) 1994-10-05
GR3007385T3 (enExample) 1993-07-30
DK365488A (da) 1988-07-01
JPH02500744A (ja) 1990-03-15
IE873125L (en) 1988-05-21
LV10954B (en) 1996-08-20
KR890700125A (ko) 1989-03-02
NO173998B (no) 1993-11-22
NO883229L (no) 1988-09-16
FI892454A7 (fi) 1989-05-19
PT86186B (pt) 1990-08-31
FI892454L (fi) 1989-05-19
EG18379A (en) 1992-11-30
EP0510719A1 (en) 1992-10-28
NZ234564A (en) 1991-04-26
WO1988003921A1 (en) 1988-06-02
YU211087A (en) 1988-12-31

Similar Documents

Publication Publication Date Title
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
YU104191A (sh) Supstituisani benzimidazoli i postupak za njihovo dobijanje
YU48854B (sh) Derivati n-(4-piperidinil) (dihidrobenzofuran ili dihidro-2h-benzopiran)karboksamida i postupak za njihovo dobijanje
HRP20021039B1 (hr) Ciklopentanoindoli, pripravci koji sadržavaju takve spojeve i metode liječenja
YU64092A (sh) Fluoralkoksibenzamino derivati heterocikličnih jedinjenja koja sadrže azot
GB1053063A (enExample)
YU30692A (sh) Novi sulfonamidski antagonisti receptora fibrinogena
GB1495526A (en) Chroman derivatives
YU45923B (sh) Novi derivati pirola
DK0753301T3 (da) Kombination af et benzimidazol med angiotensin-II-antagonistisk aktivitet med et diuretika
ATE25381T1 (de) 4-(1h-indolyl-3-)alpha-methylpiperidin-1-ethano - derivate, ihre salze, verfahren zur herstellung, zusammenstellungen die sie enthalten und deren anwendung als heilmittel.
ES431055A1 (es) Procedimiento para la preparacion de nuevos n- (metoximetil-furilmetil)-6, 7-benzomorfanos y -morfinanos.
YU47219B (sh) Antivirusna tetrahidroimidazo (1,4) benzodiazepin-2-tiona jedinjenja i postupak za njihovo dobijanje
DK164662C (da) Analogifremgangsmaade til fremstilling af pyridylphenyl- og diphenylforbindelser
ATE52250T1 (de) Dihydropyridinverbindungen, verfahren zu ihrer herstellung und ihre verwendung.
DK304289D0 (da) Hidtil ukendte forbindelser
MY101142A (en) 1, 4-dihydropyridine derivative, process for production thereof, and pharmaceutical use thereof.
FR2803593B1 (fr) Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
ES2012044B3 (es) Preparado de combinacion antihipertensivo
YU47047B (sh) Supstituisani 3-amino-2-benzoilcikloheks-2-enoni, postupak za njihovo dobijanje i primena za dobijanje herbicica
ES2004467A6 (es) Procedimiento de preparacion de nuevos derivados de 1,4 dihidro-piridina
PH20931A (en) 1,4-dihydropyridines, pharmaceutical compositions containing them and method of use thereof
ATE18667T1 (de) Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung.
GB1445595A (en) 4-aminoquinoline derivatives and intermediates for their pre paration